Nothing Special   »   [go: up one dir, main page]

NO20026222D0 - Fremgangsmåte til å behandle nötrofilrelaterte sykdommer med topiske anestesimidler - Google Patents

Fremgangsmåte til å behandle nötrofilrelaterte sykdommer med topiske anestesimidler

Info

Publication number
NO20026222D0
NO20026222D0 NO20026222A NO20026222A NO20026222D0 NO 20026222 D0 NO20026222 D0 NO 20026222D0 NO 20026222 A NO20026222 A NO 20026222A NO 20026222 A NO20026222 A NO 20026222A NO 20026222 D0 NO20026222 D0 NO 20026222D0
Authority
NO
Norway
Prior art keywords
related diseases
topical anesthetics
treating neutrophil
neutrophil
treating
Prior art date
Application number
NO20026222A
Other languages
English (en)
Other versions
NO20026222L (no
Inventor
Gerald J Gleich
Loren W Hunt
Original Assignee
Mayo Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation filed Critical Mayo Foundation
Publication of NO20026222D0 publication Critical patent/NO20026222D0/no
Publication of NO20026222L publication Critical patent/NO20026222L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20026222A 2000-06-23 2002-12-23 Fremgangsmåte til å behandle neutrofilrelaterte sykdommer med topiske anestesimidler NO20026222L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21403100P 2000-06-23 2000-06-23
PCT/US2001/019977 WO2002000218A2 (en) 2000-06-23 2001-06-22 Methods of treating neutrophil-related diseases with topical anesthetics

Publications (2)

Publication Number Publication Date
NO20026222D0 true NO20026222D0 (no) 2002-12-23
NO20026222L NO20026222L (no) 2003-02-20

Family

ID=22797503

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20026222A NO20026222L (no) 2000-06-23 2002-12-23 Fremgangsmåte til å behandle neutrofilrelaterte sykdommer med topiske anestesimidler

Country Status (9)

Country Link
US (4) US6861449B2 (no)
EP (1) EP1296683A2 (no)
JP (1) JP2004501193A (no)
AU (2) AU2001271386B2 (no)
CA (1) CA2414389A1 (no)
IL (1) IL153574A0 (no)
MX (1) MXPA03000188A (no)
NO (1) NO20026222L (no)
WO (1) WO2002000218A2 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL153574A0 (en) * 2000-06-23 2003-07-06 Mayo Foundation Methods of treating neutrophil-related diseases with topical anesthetics
US20040076671A1 (en) * 2002-10-21 2004-04-22 Aletha Tippett Methods and compositions for topical wound treatment
US6861499B2 (en) * 2003-02-24 2005-03-01 Triton Systems, Inc. Branched polyphosphonates that exhibit an advantageous combination of properties, and methods related thereto
WO2005060640A2 (en) * 2003-12-15 2005-07-07 Sarnoff Corporation Method and apparatus for object tracking prior to imminent collision detection
US7452524B2 (en) 2004-01-27 2008-11-18 Gilead Sciences, Inc. Method for improvement of tolerance for therapeutically effective agents delivered by inhalation
US7452523B2 (en) * 2004-01-27 2008-11-18 Gilead Sciences, Inc. Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks
WO2006060027A2 (en) * 2004-09-20 2006-06-08 Corus Pharma, Inc. A method for improvement of tolerance for therapeutically effective agents delivered by inhalation
CA2581209A1 (en) * 2004-09-20 2006-04-06 Corus Pharma, Inc. Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks
AU2005316687B2 (en) * 2004-12-16 2008-06-26 Alkermes, Inc. Compositions and methods for pulmonary conditions
AU2006214384A1 (en) * 2005-02-14 2006-08-24 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of IL-17F in diagnosis and therapy of airway inflammation
CA3002443A1 (en) 2006-11-20 2008-05-29 President And Fellows Of Harvard College Methods, compositions, and kits for treating pain and pruritis
JP6205133B2 (ja) * 2009-07-10 2017-09-27 プレジデント アンド フェローズ オブ ハーバード カレッジ 抗炎症剤としての恒久的に荷電したナトリウムおよびカルシウムチャンネルブロッカー
CA2994545A1 (en) 2015-08-03 2017-02-09 President And Fellows Of Harvard College Charged ion channel blockers and methods for use
KR20210143214A (ko) 2019-03-11 2021-11-26 녹시온 테라퓨틱스 인코포레이티드 하전된 이온 채널 차단제 및 사용 방법
US10934263B2 (en) 2019-03-11 2021-03-02 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
KR20210145164A (ko) 2019-03-11 2021-12-01 녹시온 테라퓨틱스 인코포레이티드 에스테르 치환된 이온 채널 차단제 및 사용 방법
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CA3155568A1 (en) 2019-11-06 2021-05-14 Bridget Mccarthy Cole Charged ion channel blockers and methods for use
AU2020380118A1 (en) 2019-11-06 2022-05-19 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP2023517604A (ja) 2020-03-11 2023-04-26 ノシオン セラピューティクス，インコーポレイテッド 荷電したイオンチャンネル遮断薬および使用方法
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
NL2025253B1 (en) * 2020-03-31 2021-10-22 Hasan Djohan Use of lidocaine in treatment of respiratory diseases
US20230128348A1 (en) * 2020-03-31 2023-04-27 Djohan HASAN Treatment of hyperinflammatory syndrome
US20210346625A1 (en) * 2020-05-07 2021-11-11 West Virginia University Board of Governors on behalf of West Virginia University Methods of improving autonomic imbalance or sympathetic impairment by regulating the stellate ganglion
CN113764038B (zh) * 2021-08-31 2023-08-22 华南理工大学 构建骨髓增生异常综合征转白基因预测模型的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103302D0 (en) * 1991-02-16 1991-04-03 Smithkline Beecham Plc Pharmaceutical formulations
US5510339A (en) * 1993-02-02 1996-04-23 Mayo Foundation For Medical Education And Research Method for the treatment of bronchial asthma by administration of topical anesthetics
CN1311673A (zh) * 1998-06-09 2001-09-05 诺特兰药品有限公司 治疗咳嗽的组合物和方法
IL153574A0 (en) * 2000-06-23 2003-07-06 Mayo Foundation Methods of treating neutrophil-related diseases with topical anesthetics

Also Published As

Publication number Publication date
US6861449B2 (en) 2005-03-01
WO2002000218A2 (en) 2002-01-03
AU2001271386B2 (en) 2005-04-07
US20040077717A1 (en) 2004-04-22
NO20026222L (no) 2003-02-20
US20090054485A1 (en) 2009-02-26
AU7138601A (en) 2002-01-08
EP1296683A2 (en) 2003-04-02
JP2004501193A (ja) 2004-01-15
US20060100276A1 (en) 2006-05-11
IL153574A0 (en) 2003-07-06
US7816374B2 (en) 2010-10-19
MXPA03000188A (es) 2003-09-22
WO2002000218A3 (en) 2002-05-16
CA2414389A1 (en) 2002-01-03
US20030171402A1 (en) 2003-09-11

Similar Documents

Publication Publication Date Title
NO20026222D0 (no) Fremgangsmåte til å behandle nötrofilrelaterte sykdommer med topiske anestesimidler
IL162533A0 (en) Chalcone derivatives and their use to treat diseases
CY2013011I1 (el) Μεθοδος χορηγησης διφωσφονικων
IS6575A (is) Hýdroxýfenýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka
IS8913A (is) Afleiður 4-tetrazólýl-4-fenýlpiperidíns til þess að meðhöndla verk
NO20040353L (no) Ny terapeutsk metode
NO20032271D0 (no) GABA-enhancere i behandlingen av sykdommer relatert til redusert nevrosteroidaktivitet
EE200300366A (et) Meetodid nahahaiguste ravimiseks või tõkestamiseks CD2-siduvate vahendite abil
PL349511A1 (en) Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites
IS6574A (is) Kínólinýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka
IS6563A (is) Hýdroxýfenýl-píperasinýl-metýl-bensamíðafleiður til að meðhöndla sársauka
NO20025722L (no) Fremgangsmåte for å behandle virale sykdommer med IL-8- og IL- 18-kombinasjoner
NO20024236D0 (no) Behandling av psoriasis
DK1503747T3 (da) Diclofenacbaseret sammensætning til topisk behandling af sygdomme
NO20032156D0 (no) Behandling av angstforstyrrelser
PT1282599E (pt) Derivados dissulfureto uteis para tratar doencas alergicas
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
PT1305314E (pt) Agente terapeutico cristalino
NO20030762L (no) Forbedret spesifisitet i behandling av sykdommer
FI20030276A (fi) Palovammojen hoitaminen
NO20023243D0 (no) Ny terapeutisk anvendelse av enoxaparin
GB0028468D0 (en) Composition for topical treatment of skin
FI20002756A0 (fi) Uusi hoitomenetelmä
NO20032885L (no) Elektrodebehandling

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application